Zhiqiang Liu

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 20

Top Venues

Nature communications

Oncogene

Science signaling

Clinical and translational medicine

Tianjin Medical University

Peking University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tianjin Medical University Sep 01 2015

China

Professor :: Physiology and Patholophysiology

University of Texas MD Anderson Cancer Center Nov 01 2014 - Dec 01 2015

United States

Instructor :: Lymphoma and Myeloma

University of Texas MD Anderson Cancer Center Aug 23 2010 - Oct 30 2014

United States

Postdoctoral fellow :: Lymphoma and Myeloma

University of Texas Health Science Center at San Antonio Dec 01 2008 - Aug 22 2010

United States

Postdoctoral fellow :: Pathology

Education History

Peking University Sep 01 2005 - Jul 01 2008

China

PHD :: Biochemistry and Molecular Biology

Publications

Xin Li, Sheng Wang, Ying Xie, Hongmei Jiang, Jing Guo, Yixuan Wang, Ziyi Peng, Meilin Hu, Mengqi Wang, Jingya Wang, Qian Li, Yafei Wang, Zhiqiang Liu
Deacetylation induced nuclear condensation of HP1γ promotes multiple myeloma drug resistance. Nature communications 14 (1) (2023)
Jinxing Jiang, Ziyi Peng, Junying Wang, Mengping Chen, Yike Wan, Honghui Huang, Zhiqiang Liu, Jingya Wang, Jian Hou
C-reactive protein impairs immune response of CD8 + T cells via FcγRIIb-p38MAPK-ROS axis in multiple myeloma. Journal for immunotherapy of cancer 11 (10) (2023)
Xin Li, Sheng Wang, Ying Xie, Hongmei Jiang, Jing Guo, Yixuan Wang, Ziyi Peng, Meilin Hu, Mengqi Wang, Jingya Wang, Qian Li, Yafei Wang, Zhiqiang Liu
Deacetylation induced nuclear condensation of HP1γ promotes multiple myeloma drug resistance. Nature communications 14 (1) (2023)
Xin Li, Sheng Wang, Ying Xie, Hongmei Jiang, Jing Guo, Yixuan Wang, Ziyi Peng, Meilin Hu, Mengqi Wang, Jingya Wang, Qian Li, Yafei Wang, Zhiqiang Liu
Deacetylation induced nuclear condensation of HP1γ promotes multiple myeloma drug resistance. Nature communications 14 (1) (2023)
Xin Li, Sheng Wang, Ying Xie, Hongmei Jiang, Jing Guo, Yixuan Wang, Ziyi Peng, Meilin Hu, Mengqi Wang, Jingya Wang, Qian Li, Yafei Wang, Zhiqiang Liu
Deacetylation induced nuclear condensation of HP1γ promotes multiple myeloma drug resistance. Nature communications 14 (1) (2023)
Jingya Wang, Ziyi Peng, Jing Guo, Yixuan Wang, Sheng Wang, Hongmei Jiang, Mengqi Wang, Ying Xie, Xin Li, Meilin Hu, Yangyang Xie, Hao Cheng, Tiantian Li, Linchuang Jia, Jia Song, Yafei Wang, Jian Hou, Zhiqiang Liu
CXCL10 recruitment of γδ T cells into the hypoxic bone marrow environment leads to IL-17 expression and multiple myeloma progression. Cancer immunology research (2023)
Meilin Hu, Liangyu Xing, Li Zhang, Fan Liu, Sheng Wang, Ying Xie, Jingjing Wang, Hongmei Jiang, Jing Guo, Xin Li, Jingya Wang, Lei Sui, Changyi Li, Dayong Liu, Zhiqiang Liu
NAP1L2 drives mesenchymal stem cell senescence and suppresses osteogenic differentiation. Aging cell 21 (2) (2022)
Ying Xie, Na Han, Feng Li, Lijuan Wang, Gerui Liu, Meilin Hu, Sheng Wang, Xuelei Wei, Jing Guo, Hongmei Jiang, Jingjing Wang, Xin Li, Yixuan Wang, Jingya Wang, Xiyun Bian, Zhongjiao Zhu, Hui Zhang, Chunhua Liu, Xiaozhi Liu, Zhiqiang Liu
Melatonin enhances osteoblastogenesis of senescent bone marrow stromal cells through NSD2-mediated chromatin remodelling. Clinical and translational medicine 12 (2) (2022)
Jing Guo, Yangyang Lv, Sheng Wang, Ziyi Peng, Ying Xie, Yixuan Wang, Hongmei Jiang, Xin Li, Mengqi Wang, Meilin Hu, Jiangpeng Mu, Jingya Wang, Yangyang Xie, Xiankui Cheng, Zhigang Zhao, Zhiqiang Liu
Hypoxia induces chemoresistance to proteasome inhibitors through orchestrating deSUMOylation and ubiquitination of SRC-3 in multiple myeloma. Oncogene 41 (45) (2022)
Hongmei Jiang, Yixuan Wang, Jingjing Wang, Yafei Wang, Sheng Wang, Enyang He, Jing Guo, Ying Xie, Jingya Wang, Xin Li, Ziyi Peng, Mengqi Wang, Jian Hou, Zhiqiang Liu
Posttranslational modification of Aurora A-NSD2 loop contributes to drug resistance in t(4;14) multiple myeloma. Clinical and translational medicine 12 (4) (2022)
Xin Li, Jingjing Wang, Shuai Zhu, Jinxin Zheng, Ying Xie, Hongmei Jiang, Jing Guo, Yixuan Wang, Ziyi Peng, Mengqi Wang, Jingya Wang, Sheng Wang, Yuping Zhong, Zhiqiang Liu
DKK1 activates noncanonical NF-κB signaling via IL-6-induced CKAP4 receptor in multiple myeloma. Blood advances 5 (18) (2021)
Yinyin Xu, Jing Guo, Jing Liu, Ying Xie, Xin Li, Hongmei Jiang, Jingjing Wang, Ziyi Peng, Jingya Wang, Sheng Wang, Chao Wan, Lanting Chen, Yuping Zhong, Bei-Zhong Liu, Zhiqiang Liu
Hypoxia-induced CREB cooperates MMSET to modify chromatin and promote DKK1 expression in multiple myeloma. Oncogene 40 (7) (2021)
Qiguo Zhang, Wenyu Gong, Hongyan Wu, Jing Wang, Qichuan Jin, Chun Lin, Shiyun Xu, Wenqiang Bao, Yin Wang, Jing Wu, Shanshan Feng, Changzhi Zhao, Bing Chen, Zhiqiang Liu
DKK1 suppresses WWP2 to enhance bortezomib resistance in multiple myeloma via regulating GLI2 ubiquitination. Carcinogenesis 42 (10) (2021)
Jing Liu, Ying Xie, Jing Guo, Xin Li, Jingjing Wang, Hongmei Jiang, Ziyi Peng, Jingya Wang, Sheng Wang, Qian Li, Linquan Ye, Yuping Zhong, Qiguo Zhang, Xiaozhi Liu, David M Lonard, Jin Wang, Bert W O' Malley, Zhiqiang Liu
Targeting NSD2-mediated SRC-3 liquid-liquid phase separation sensitizes bortezomib treatment in multiple myeloma. Nature communications 12 (1) (2021)
Huan Liu, Jin He, Su Pin Koh, Yuping Zhong, Zhiqiang Liu, Zhiqiang Wang, Yujin Zhang, Zongwei Li, Bjorn T Tam, Pei Lin, Min Xiao, Ken H Young, Behrang Amini, Michael W Starbuck, Hans C Lee, Nora M Navone, Richard Eric Davis, Qiang Tong, Peter Leif Bergsagel, Jian Hou, Qing Yi, Robert Z Orlowski, Robert F Gagel, Jing Yang
Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease. Science translational medicine 11 (494) (2020)
Zhiqiang Liu, Huan Liu, Jin He, Pei Lin, Qiang Tong, Jing Yang
Myeloma cells shift osteoblastogenesis to adipogenesis by inhibiting the ubiquitin ligase MURF1 in mesenchymal stem cells. Science signaling 13 (633) (2020)
Ying Xie, Jing Liu, Hongmei Jiang, Jingya Wang, Xin Li, Jingjing Wang, Shuai Zhu, Jing Guo, Tao Li, Yuping Zhong, Qiguo Zhang, Zhiqiang Liu
Proteasome inhibitor induced SIRT1 deacetylates GLI2 to enhance hedgehog signaling activity and drug resistance in multiple myeloma. Oncogene 39 (4) (2019)
Tao Li, Xia Zhang, Kesheng Jiang, Jing Liu, Zhiqiang Liu
Dural effects of oxidative stress on cardiomyogenesis via Gata4 transcription and protein ubiquitination. Cell death & disease 9 (2) (2018)
Yiping Sun, Ying Xie, Luping Du, Jingwu Sun, Zhiqiang Liu
Inhibition of BRD4 attenuates cardiomyocyte apoptosis via NF-κB pathway in a rat model of myocardial infarction. Cardiovascular therapeutics 36 (2) (2018)
Jing Yang, Zhiqiang Liu, Huan Liu, Jin He, Jianling Yang, Pei Lin, Qiang Wang, Juan Du, Wencai Ma, Zheng Yin, Richard Eric Davis, Robert Z Orlowski, Jian Hou, Qing Yi
C-reactive protein promotes bone destruction in human myeloma through the CD32-p38 MAPK-Twist axis. Science signaling 10 (509) (2017)

Zhiqiang Liu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Zhiqiang Liu